Product Information
BUPRENORPHINE 8 MG TABLET SL is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.5676 per EA under NDC 42858050203. Its NADAC has been published 440 times since Mar 21, 2018.
FDA first approved this application on Mar 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858050203
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207276FDA Approved
3/27/2017
TE Code
AB
On Market Since
10/25/2017
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 8 MG TABLET SL has been published 440 times since Mar 21, 2018, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5676 per EA |
|---|---|
| All-time high | $1.3341 (Apr 11, 2018) |
| All-time low | $0.5567 (Apr 22, 2026) |
| 52-week high | $0.7210 |
| 52-week low | $0.5567 |
| Median price | $0.8258 |
| Average price | $0.8679 |
| Largest weekly change | +27.5% (Aug 21, 2024) |
| Weeks tracked | 440 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUPRENORPHINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 8 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 8 MG TABLET SL, manufactured by Rhodes Pharmaceuticals L.P., is $0.5676 per EA (NDC 42858050203), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 8 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 8 MG TABLET SL has declined 57.5%. It has been tracked across 440 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 8 MG TABLET SL?
Since Mar 21, 2018, the NADAC for BUPRENORPHINE 8 MG TABLET SL has ranged from a low of $0.5567 (Apr 22, 2026) to a high of $1.3341 (Apr 11, 2018), with a median of $0.8258 per EA.
Are there cheaper alternatives to BUPRENORPHINE 8 MG TABLET SL?
No other NADAC-published product currently shares the active ingredient and strength of BUPRENORPHINE 8 MG TABLET SL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUPRENORPHINE 8 MG TABLET SL?
BUPRENORPHINE 8 MG TABLET SL (NDC 42858050203) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.